Synopsis
0
CEP/COS
0
JDMF
0
VMF
0
Europe
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ABOUT THIS PAGE
A Lifitegrast manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Lifitegrast, including repackagers and relabelers. The FDA regulates Lifitegrast manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Lifitegrast API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Lifitegrast manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Lifitegrast supplier is an individual or a company that provides Lifitegrast active pharmaceutical ingredient (API) or Lifitegrast finished formulations upon request. The Lifitegrast suppliers may include Lifitegrast API manufacturers, exporters, distributors and traders.
click here to find a list of Lifitegrast suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Lifitegrast DMF (Drug Master File) is a document detailing the whole manufacturing process of Lifitegrast active pharmaceutical ingredient (API) in detail. Different forms of Lifitegrast DMFs exist exist since differing nations have different regulations, such as Lifitegrast USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Lifitegrast DMF submitted to regulatory agencies in the US is known as a USDMF. Lifitegrast USDMF includes data on Lifitegrast's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Lifitegrast USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Lifitegrast suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Lifitegrast Drug Master File in Korea (Lifitegrast KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Lifitegrast. The MFDS reviews the Lifitegrast KDMF as part of the drug registration process and uses the information provided in the Lifitegrast KDMF to evaluate the safety and efficacy of the drug.
After submitting a Lifitegrast KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Lifitegrast API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Lifitegrast suppliers with KDMF on PharmaCompass.
A Lifitegrast written confirmation (Lifitegrast WC) is an official document issued by a regulatory agency to a Lifitegrast manufacturer, verifying that the manufacturing facility of a Lifitegrast active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Lifitegrast APIs or Lifitegrast finished pharmaceutical products to another nation, regulatory agencies frequently require a Lifitegrast WC (written confirmation) as part of the regulatory process.
click here to find a list of Lifitegrast suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Lifitegrast as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Lifitegrast API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Lifitegrast as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Lifitegrast and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Lifitegrast NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Lifitegrast suppliers with NDC on PharmaCompass.
Lifitegrast Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Lifitegrast GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Lifitegrast GMP manufacturer or Lifitegrast GMP API supplier for your needs.
A Lifitegrast CoA (Certificate of Analysis) is a formal document that attests to Lifitegrast's compliance with Lifitegrast specifications and serves as a tool for batch-level quality control.
Lifitegrast CoA mostly includes findings from lab analyses of a specific batch. For each Lifitegrast CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Lifitegrast may be tested according to a variety of international standards, such as European Pharmacopoeia (Lifitegrast EP), Lifitegrast JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Lifitegrast USP).
LOOKING FOR A SUPPLIER?
